IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
fac ture: Niels Hansen; Mar ket Re search: Mogens
Skov; Gen eral Con tact: Pernille Marhaver
Par ent of: Sandoz AB, Swe den.
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 50-55 mil lion
Prod ucts (% of Sales by Lead ing 5): 30-35%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
DICILLIN (pen i cil lin me dium/nar row spec trum)
NOVYNETTE (hor monal con tra cep tive sys temic)
ISODUR (ni trite/ni trate)
LINDYNETTE (hor monal con tra cep tive sys temic)
MANDOLGIN (an al ge sic non-nar cotic)
Ther a peu tic Range:
antibacterials sys temic 26%
sex hor mones sys temic 18%
an al ge sics 8%
psycholeptics 6%
psychoanaleptics 4%
Lead ing Dose Forms:
coated tab lets 36%
tab lets 30%
cap sules 27%
am poules 4%
vi als 1%
DOMINICAN REPUBLIC
NOVARTIS
Full Name: Novartis Caribe S.A.
Postal Ad dress: Apartado Postal 736, Santo
Domingo
Street Ad dress: Av. 27 de Febrero, No. 18
Miraflores, Santo Domingo
Tel: +1 809 686-7676
Fax: +1 809 687-7972
De scrip tion: Im porter, dis trib u tor, pro moter,
sales/detailer. Im ports, dis trib utes for other com -
pa nies. Prod uct ranges in clude: phar ma ceu ti cal
prod ucts (branded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals, vet er i nary
pharmaceuticals. Es tab lished 1997. Di vi sions
include: Biochemie.
Con tacts (Pharm): Chair man: Diego Cuesta;
Com mer cial Op er a tions: Rob ert O’Sullivan
Phar ma ceu ti cal Sales: US$ 10-12 mil lion
Prod ucts (% of Sales by Lead ing 5): 55-60%
Ther a peu tic Classes (% of Sales by Lead ing
5): 80-85%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CATAFLAM (antirheumatic non-steroidal)
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
VOLTAREN (antirheumatic non-steroidal)
DIOVAN FCT (an gio ten sin-II an tag o nist plain)
PANTECTA (antiulcerant)
Ther a peu tic Range:
anti rheu ma tics sys temic 38%
renin-an gio ten sin sys tem agents 25%
antiepileptics 8%
antiasthma and COPD prod ucts 6%
ant ac ids/antiflatulents/antiulcerants 5%
Lead ing Dose Forms:
coated tab lets 51%
tab lets 16%
cap sules 16%
liq uids 6%
sup pos i to ries 4%
SANDOZ
Street Ad dress: Ho tel Do min i can Fi esta,
Avenida Anacaona, Los Casicaszgos, Santo
Domingo
Tel: +1 809 482-5701
Fax: +1 809 482-3310
Email: sandoz@codetel.net.do
De scrip tion: 18 phar ma ceu ti cal em ploy ees in
2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 15 (2007)
Con tacts (Pharm): Chair man: Da vid Thomp -
son; Com mer cial Op er a tions: Da vid Thomp son;
Gen eral Con tact: Da vid Thompson
ECUADOR
NOVARTIS
Full Name: Novartis Ec ua dor SA
Postal Ad dress: Casilla 17-11-06201, Quito
Street Ad dress: Av Republico de El Sal va dor,
N34-107 y Suiza, Ed. Brescia Piso 4, Quito
Tel: +593 2 246-4054
Fax: +593 2 246-1394
De scrip tion: Packager/as sem bler, im porter, dis -
trib u tor, pro moter, sales/detailer. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion, non-pre scrip tion), oph thal mic prod ucts.
Es tab lished 1974. 125 phar ma ceu ti cal em ploy ees
in 2005. Di vi sions in clude: Novartis Con sumer
© 2009 IMS Health In cor po rated or its af fil i ates Page 163